Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number

##

Overview

Projects 285
Countries 141
Faculty 357
Health Topics 122

Filter from the selections below

Clear All Filters
Back to search

Development of a pre-erythrocytic P. vivax vaccine to prevent clinical relapse

The goal of this project is the development of a vaccine targeting the pre-erythrocytic stages of malaria infection to prevent relapse infection by Plasmodium vivax. Because 80-90% of active blood stage P. vivax infections come from relapse, and not primary infection, a vaccine against relapse infection would significantly impact transmission worldwide.

Countries 
Active Dates 
01/01/2019 to 12/31/2023
Faculty Involved 
Health Topics